Opioids drugs comprise of strong pain killers, illegal pain relievers such as oxycodone, fentanyl, hydrocodone, and morphine, and illicit drugs like heroin. These drugs are also legally available on prescription. Opioid drugs are known for use of cancer related and acute pain management in all age group of patients. However, use of opioid drugs in noncancerous patients can be controversial due to psychological addiction that is caused by non-stop use of opioid drugs. Other side effects of opioid drugs use are sedation, constipation, nausea, vomiting, dizziness, headache, sweating, physical dependence, and respiratory depression. Among all these side effects, constipation is the most common side effect observed in 40 to 95% of patients using opioids in treatments.
Get FREE Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/387
Increasing use of prescription based opioids causing diseases related to them is expected to propel growth of the global opioid induced side effects treatment market in coming future. For instance, in February 2017, National Institute on Drug Abuse (NIDA) published stats according to which, cocaine overdose related deaths increase despite the use of cocaine was decreased after 2010. These deaths were related to opioids, mainly with synthetic.
Moreover, in 2013, the NIDA estimated 2017 million prescriptions for opioids were given across the globe, where North America accounted for major share in 2012. Prescription based opioids such as pain relievers affect 2.1 million people in the U.S. out of which, 467,000 people have addiction of heroin.
Furthermore, increasing prevalence of opioid is expected to boost growth of the global opioid induced side effects treatment market. For instance, in 2010, United Nations Office on Drugs and Crime (UNODC) reported that 0.6-0.8% opioid occurs in population of 15-64 age group and 0.3-0.5% in the people aging more than 64 years.
In 2015, Centers for Disease Control and Prevention (CDC) reported that overdose of opioids caused more than 15,000 deaths in the U.S. and the rate of death caused by over dose was high in age group between 25-54 years. Moreover, in 2014, nearly 2 million people were dependent on prescribed opioids and 1 out 4 people used these drugs for addiction.
A small percentage of opioid users receive treatment and the number of people requiring the treatment option is increasing in developed and middle-income economies creating scope for manufacturers to develop and produce treatment for opioid induced side effects, which in turn is expected to fuel growth of the global opioid induced side effects treatment market.
By Dosage Form of Drug
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/387
Among regions, North America is expected to witness strong growth in the market of opioid induced side effects treatment due to presence of highest number of prescription based opioids consumers. For instance, in 2013, according to NIDA, among all the other regions, the U.S. had 100% cases of hydrocodone such as Norco, Lortab, and Vicodin, and 81% of oxycodone such as Percocet and Endocet. Moreover, in 2015, according to American Society of Addiction Medicine (ASAM), drug overdose caused 12,990 deaths related to prescription based pain relievers.
Furthermore, Europe and APAC region are also expected to witness high growth in the opioid induced side effects treatment market in the coming future. According to the data published in 2012 by UNODC, Africa and Asia Pacific are expected to witness growth in the market due to increasing opioid consumption and growing demand for treatment against drug dependence in Asia Pacific.
Major players in the global opioid induced side effects treatment market include Cubist Pharmaceuticals, Inc., SLA Pharma AG, AstraZeneca plc., Shionogi & Co., Ltd., AIKO Biotechnology, Inc., and Progenics Pharmaceuticals Inc.
𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐨 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐭𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/387
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Opioid Induced Side Effects Treatment Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Opioid Induced Side Effects Treatment Industry Impact
Chapter 2 Global Opioid Induced Side Effects Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Opioid Induced Side Effects Treatment (Volume and Value) by Type
2.3 Global Opioid Induced Side Effects Treatment (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Opioid Induced Side Effects Treatment Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Opioid Induced Side Effects Treatment Market Analysis
Chapter 6 East Asia Opioid Induced Side Effects Treatment Market Analysis
Chapter 7 Europe Opioid Induced Side Effects Treatment Market Analysis
Chapter 8 South Asia Opioid Induced Side Effects Treatment Market Analysis
Chapter 9 Southeast Asia Opioid Induced Side Effects Treatment Market Analysis
Chapter 10 Middle East Opioid Induced Side Effects Treatment Market Analysis
Chapter 11 Africa Opioid Induced Side Effects Treatment Market Analysis
Chapter 12 Oceania Opioid Induced Side Effects Treatment Market Analysis
Chapter 13 South America Opioid Induced Side Effects Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Opioid Induced Side Effects Treatment Business
Chapter 15 Global Opioid Induced Side Effects Treatment Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027